Brief: FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals

Kyntra Bio

03/06/2024 21:07

June 3 (Reuters) - FibroGen Inc  FGEN.O :
    * FIBROGEN ANNOUNCES CLINICAL TRIAL SUPPLY AGREEMENT WITH
REGENERON PHARMACEUTICALS TO EVALUATE FIBROGEN’S IMMUNO-ONCOLOGY
ASSETS, FG-3165 (ANTI-GALECTIN 9) AND FG-3175 (ANTI-CCR8), IN
COMBINATION WITH LIBTAYO® IN UPCOMING CLINICAL TRIALS
    * FIBROGEN INC -BOTH FG-3165 AND FG-3175 HAVE DEMONSTRATED
COMPLEMENTARY MECHANISMS OF ACTION WITH PD-1 INHIBITORS IN
PRECLINICAL STUDIES

Source text for Eikon:  ID:nGNX90rxf2 
Further company coverage:  FGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))